Vascular Access Device Market by Type (Peripheral (Midline, Short), Central (PICC, Tunneled, Non-Tunneled, Implanted Ports), Accessories), Application (Drug Administration, Fluid & Nutrition Administration) & End Users - Global Forecasts to 2022

血管アクセスデバイスの世界市場予測(~2022年)

◆タイトル:Vascular Access Device Market by Type (Peripheral (Midline, Short), Central (PICC, Tunneled, Non-Tunneled, Implanted Ports), Accessories), Application (Drug Administration, Fluid & Nutrition Administration) & End Users - Global Forecasts to 2022
◆商品コード:MAM-MD5434
◆調査・発行会社:MarketsandMarkets
◆発行日:2017年7月21日
◆ページ数:141
◆レポート形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名利用)USD5,650 ⇒換算¥615,850見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥724,850見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥888,350見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

当調査レポートでは、血管アクセスデバイスの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、種類別分析、用途別分析、需要先別分析、地域別分析、血管アクセスデバイスの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。

・イントロダクション
・エグゼクティブサマリー
・血管アクセスデバイスの世界市場:市場インサイト
・血管アクセスデバイスの世界市場:市場概観/市場動向
・血管アクセスデバイスの世界市場:市場シェア分析
・血管アクセスデバイスの世界市場:種類別分析/市場規模
・血管アクセスデバイスの世界市場:用途別分析/市場規模
・血管アクセスデバイスの世界市場:需要先別分析/市場規模
・血管アクセスデバイスの世界市場:地域別分析/市場規模
・血管アクセスデバイスのアジア市場規模予測
・血管アクセスデバイスのヨーロッパ市場規模予測
・血管アクセスデバイスのアメリカ市場規模予測
・血管アクセスデバイスの世界市場動向
・血管アクセスデバイスの世界市場:競争状況
・血管アクセスデバイスの世界市場:関連企業分析
...

※上記の和訳は最新内容ではない場合があります。下記の英文概要・目次が最新版です。

“Vascular access devices market is projected to grow at a CAGR of 7.1%”The global vascular access device market is estimated to grow at a CAGR of 7.1% to reach USD 5.45 billion by 2022 from USD 3.87 billion in 2017. The key factors driving the growth of this market include the growing prevalence of lifestyle diseases, an increase in the number of chemotherapy procedures and the increasing use of vascular access devices in pediatric patients. However, high costs involved in the placement and maintenance of vascular access devices and product recalls and failures may hinder the growth of the market to a certain extent during the forecast period.

“The central vascular access device segment to dominate the global vascular access devices market during the forecast period”
By type, the vascular access devices market is segmented into central vascular access devices, peripheral vascular access devices, and accessories. The central vascular access devices segment is not only expected to account for the largest share of the vascular access devices market in 2017, but also grow at the highest CAGR during the forecast period. The growth of this segment is attributed to the wide usage of central vascular access devices in chemotherapy and for the treatment of cardiovascular disorders and chronic kidney disorders.

“The drug administration segment is projected to grow at the highest CAGR during the forecast period”
On the basis of application, the vascular access devices market is segmented into drug administration, fluid and nutrition administration, blood transfusion, and diagnostics & testing. The drug administration segment is expected to grow at the highest CAGR in 2017. This positive growth rate can primarily be attributed to the high usage of vascular access devices for drug administration for the treatment of infections, cancer, and other diseases.

“Asia-Pacific to witness the highest growth during the forecast period (2017-2022)”
North America held the largest share of the global vascular access devices market in 2016, while Asia-Pacific is expected to witness the highest growth during 2017 to 2022. Rapid growth in aging population and CKD, CKS, & diabetes prevalence, along with healthcare reforms and investments in Asia-Pacific countries, are key factors driving the market for this geographic segment.

Break of primary participants was as mentioned below:
• By Company Type – Tier 1–55%, Tier 2–25% and Tier 3–20%
• By Designation – C-level–43%, Director Level–32%, Others–25%
• By Region – North America–38%, Europe–23%, Asia-Pacific–29%, RoW–10%

Some of the major players include Becton Dickinson and Company (U.S.), Smiths Medical, Inc. (U.K.), and C. R. Bard, Inc. (U.S.). Other players include Teleflex Incorporated (U.S.) B. Braun Melsungen Ag (Germany), AngioDynamics (U.S.), Terumo Corporation (Japan), Nipro Medical Corporation, Edwards Lifesciences Corporation (U.S.), Ameco Medical (Egypt), Romsons Scientific & Surgical Pvt. Ltd (India), and Prodimed (France).

Research Coverage:
The report analyzes the vascular access device market and aims at estimating the market size and future growth potential of this market based on various segments such as type, application, end user and region. The report also includes an in-depth regulatory analysis for various regions across the globe and the competitive analysis of the key players in this market along with their company profiles, product and service offerings, recent developments, and key market strategies.

Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn, would help them garner a greater share. Firms purchasing the report could use one or any combination of the below-mentioned five strategies.

This report provides insights on the following pointers:
• Market Penetration: Comprehensive information on product and service portfolios offered by the top players in the global vascular access devices market. The report analyzes the vascular access devices market by type, application, end user, and region.
• Service Enhancement/Innovation: Detailed insights on upcoming trends and new service launches in the global vascular access devices market.
• Market Development: Comprehensive information about the lucrative emerging markets by type, application, end user, and region.
• Market Diversification: Exhaustive information about new services or service enhancements, growing geographies, recent developments, and investments in the vascular access devices market.
• Competitive Assessment: In-depth assessment of market shares, growth strategies, products and services of leading players in the global vascular access devices market

【レポートの目次】

TABLE OF CONTENTS

1 INTRODUCTION 14
1.1 OBJECTIVES OF THE STUDY 14
1.2 MARKET DEFINITION 14
1.3 MARKET SCOPE 14
1.3.1 MARKETS COVERED 15
1.3.2 YEARS CONSIDERED FOR THE STUDY 15
1.4 CURRENCY 16
1.5 LIMITATIONS 16
1.6 STAKEHOLDERS 16

2 RESEARCH METHODOLOGY 17
2.1 RESEARCH METHODOLOGY STEPS 17
2.2 SECONDARY AND PRIMARY RESEARCH METHODOLOGY 18
2.2.1 SECONDARY RESEARCH 18
2.2.1.1 Key data from secondary sources 18
2.2.2 PRIMARY RESEARCH 19
2.2.2.1 Key insights from primary sources 21
2.2.3 KEY INDUSTRY INSIGHTS 22
2.3 MARKET SIZE ESTIMATION METHODOLOGY 22
2.4 MARKET FORECAST METHODOLOGY 24
2.5 MARKET DATA VALIDATION AND TRIANGULATION 25
2.6 ASSUMPTIONS OF THE STUDY 26

3 EXECUTIVE SUMMARY 27

4 PREMIUM INSIGHTS 31
4.1 VASCULAR ACCESS DEVICES: MARKET OVERVIEW (2017-2022) 31
4.2 VASCULAR ACCESS DEVICES MARKET, BY TYPE (2017) 32
4.3 VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2017 VS. 2022 33
4.4 VASCULAR ACCESS DEVICES MARKET, BY END USER, 2017 VS. 2022 33
4.5 GEOGRAPHIC SNAPSHOT OF THE VASCULAR ACCESS DEVICES MARKET 34

5 MARKET OVERVIEW 35
5.1 INTRODUCTION 36
5.2 MARKET DYNAMICS 36
5.2.1 DRIVERS 37
5.2.1.1 Growing prevalence of lifestyle diseases 37
5.2.1.2 Increasing number of chemotherapy procedures 37
5.2.1.3 Increasing use of vascular access devices in pediatric patients 37
5.2.2 RESTRAINTS 38
5.2.2.1 High costs involved in the placement and maintenance of vascular access devices 38
5.2.2.2 Product recalls and failures 38
5.2.3 OPPORTUNITY 39
5.2.3.1 Technological advancements 39
5.2.4 CHALLENGES 39
5.2.4.1 Shortage of skilled professionals 39
5.2.4.2 Risks associated with vascular access devices 40

6 GLOBAL VASCULAR ACCESS DEVICES MARKET, BY TYPE 41
6.1 INTRODUCTION 42
6.2 CENTRAL VASCULAR ACCESS DEVICES 43
6.2.1 PERIPHERALLY INSERTED CENTRAL CATHETERS 44
6.2.2 TUNNELED CATHETERS 45
6.2.3 NON-TUNNELED CATHETERS 46
6.2.4 IMPLANTED PORTS 47
6.3 PERIPHERAL VASCULAR ACCESS DEVICES 48
6.3.1 PERIPHERAL SHORT DEVICES 49
6.3.2 PERIPHERAL MIDLINE DEVICES 50
6.3.3 BUTTERFLY/WINGED STEEL NEEDLES 50
6.4 ACCESSORIES 51

7 GLOBAL VASCULAR ACCESS DEVICES MARKET, BY APPLICATION 52
7.1 INTRODUCTION 53
7.2 DRUG ADMINISTRATION 54
7.3 FLUID AND NUTRITION ADMINISTRATION 54
7.4 BLOOD TRANSFUSION 55
7.5 DIAGNOSTICS AND TESTING 56

8 GLOBAL VASCULAR ACCESS DEVICES MARKET, BY END USER 57
8.1 INTRODUCTION 58
8.2 HOSPITALS 59
8.3 CLINICS AND AMBULATORY CARE CENTERS 59
8.4 OTHER END USERS 60

9 VASCULAR ACCESS DEVICES MARKET, BY REGION 61
9.1 INTRODUCTION 62
9.2 NORTH AMERICA 63
9.2.1 U.S. 66
9.2.1.1 Rising prevalence of CVD 66
9.2.1.2 Increasing number of cancer cases 66
9.2.1.3 Increase in research and clinical trials for vascular access devices 66
9.2.1.4 Conferences, meetings, symposia, and workshops 67
9.2.2 CANADA 69
9.2.2.1 Increasing number of cardiac arrest cases 69
9.2.2.2 Increase in cancer incidence 69
9.2.2.3 Increasing number of minimally invasive procedures 69
9.3 EUROPE 72
9.3.1 INCREASING FOCUS OF MARKET PLAYERS ON EUROPE 72
9.3.2 NEW RULES AND REGULATIONS FOR MEDICAL DEVICES 72
9.3.3 RISING GERIATRIC POPULATION 72
9.3.4 E-3 76
9.3.4.1 Rising prevalence of CVD in U.K. and Germany 76
9.3.4.2 Growing prevalence of cancer in EU-3 77
9.3.4.3 Increasing prevalence of lifestyle diseases in the U.K. 78
9.3.4.4 Favorable government support, growth in aging population in France 78
9.3.4.5 Prevalence of ESRD and need for dialysis treatment 78
9.3.5 ROE 80
9.3.5.1 Improving healthcare structure in Russia 80
9.3.5.2 Turkey: Growth in the healthcare sector, rising medical tourism 81
9.4 ASIA-PACIFIC 83
9.4.1 INCREASING CHRONIC KIDNEY DISEASE PREVALENCE IN JAPAN 83
9.4.2 JAPAN & CHINA: RAPID GROWTH IN GERIATRIC POPULATION 83
9.4.3 HEALTHCARE REFORMS, GOVERNMENT INITIATIVES, AND INVESTMENTS IN CHINA AND JAPAN 83
9.5 REST OF THE WORLD 87
9.5.1 PREVALENCE OF CKD AND GOVERNMENT INITIATIVES IN THE ROW 87
9.5.2 MIDDLE EAST: INCREASING GERIATRIC POPULATION, RISE IN AGE-RELATED DISORDERS 87
9.5.3 GROWING MEDICAL TOURISM IN THE ROW 87
9.5.4 HIGH PREVALENCE OF OBESITY IN LATIN AMERICA 88

10 COMPETITIVE LANDSCAPE 92
10.1 OVERVIEW 92
10.2 MARKET SHARE ANALYSIS 92
10.3 MARKET RANKING (AS OF 2016) 93
10.3.1 VENDOR INCLUSION CRITERIA 93
10.4 COMPETITIVE LEADERSHIP MAPPING (2017) 93
10.4.1 VISIONARY LEADERS 93
10.4.2 INNOVATORS 93
10.4.3 DYNAMIC DIFFERENTIATORS 93
10.4.4 EMERGING COMPANIES 94
10.5 COMPETITIVE BENCHMARKING 95
10.5.1 STRENGTH OF PRODUCT PORTFOLIO 95
10.5.2 BUSINESS STRATEGY EXCELLENCE 96
*Top 25 companies analyzed for this studies are – Smiths Medical (U.S.), Terumo Medical Corporation (Japan), Becton Dickinson and Company (U.S.), Teleflex Incorporated (U.S.), C.R.Bard, Inc. (U.S.), B Braun Melsungen AG. (Germany), NIPRO Medical Corporation (Japan), Vygon Ltd. (U.K.), Ameco Medical (Egypt), Romson Scientific (India), PRODIMED (France), Edward Lifescience Corporation LLC (U.S.), AngioDynamics (U.S.), Biosensors International Group, Ltd (Singapore), Centurion Medical Products (U.S.), Fresenius Medical Care Asia Pacific Limited (Hong Kong), Access Scientific, LLC (U.S.), 3M. (U.S.), ZOLL Medical Corporation (U.S.), Medtronic Plc (Ireland), Baxter International Inc. (U.S.), Merit Medical System, Inc. (U.S.), Hospira (U.S.), Bionic Medizintechnik GmbH (Germany), Medical Components, Inc. (U.S)

11 COMPANY PROFILES 97
(Overview, Products Offered, Strength of Product Portfolio, Business Strategy Excellence, Recent Developments)*
11.1 BECTON, DICKINSON AND COMPANY 97
11.2 C.R.BARD, INC. 100
11.3 TELEFLEX INCORPORATED 103
11.4 SMITHS MEDICAL, INC. 106
11.5 B BRAUN MELSUNGEN AG 109
11.6 ANGIODYNAMICS (NAVILYST MEDICAL, INC) 113
11.7 TERUMO CORPORATION 116
11.8 NIPRO MEDICAL CORPORATION 119
11.9 EDWARDS LIFESCIENCES CORPORATION 122
11.10 AMECO MEDICAL 124
11.11 ROMSONS SCIENTIFIC & SURGICAL PVT. LTD. 126
11.12 PRODIMED 128

*Details on MarketsandMarkets view, Overview, Products Offered, Strength of Product Portfolio, Business Strategy Excellence, and Recent Developments might not be captured in case of unlisted companies.

12 APPENDIX 130
12.1 DISCUSSION GUIDE 130
12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 133
12.3 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 135
12.4 AVAILABLE CUSTOMIZATIONS 136
12.5 RELATED REPORTS 137
12.6 AUTHOR DETAILS 138

LIST OF TABLES

TABLE 1 GLOBAL VASCULAR ACCESS DEVICES MARKET, BY TYPE,
2015–2022 (USD MILLION) 42
TABLE 2 GLOBAL CENTRAL VASCULAR ACCESS DEVICES MARKET, BY TYPE,
2015–2022 (USD MILLION) 44
TABLE 3 CENTRAL VASCULAR ACCESS DEVICES MARKET, BY REGION,
2015–2022 (USD MILLION) 44
TABLE 4 PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET, BY REGION,
2015–2022 (USD MILLION) 45
TABLE 5 TUNNELED CATHETERS MARKET, BY REGION, 2015–2022 (USD MILLION) 46
TABLE 6 NON-TUNNELED CATHETERS MARKET, BY REGION, 2015–2022 (USD MILLION) 46
TABLE 7 IMPLANTED PORTS MARKET, BY REGION, 2015–2022 (USD MILLION) 47
TABLE 8 GLOBAL PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE,
2015–2022 (USD MILLION) 48
TABLE 9 PERIPHERAL VASCULAR ACCESS DEVICES MARKET SIZE, BY REGION,
2015–2022 (USD MILLION) 49
TABLE 10 PERIPHERAL SHORT DEVICES MARKET SIZE, BY REGION,
2015–2022 (USD MILLION) 49
TABLE 11 PERIPHERAL MIDLINE DEVICES MARKET, BY REGION, 2015–2022 (USD MILLION) 50
TABLE 12 BUTTERFLY/WINGED STEEL NEEDLES MARKET SIZE, BY REGION,
2015–2022 (USD MILLION) 51
TABLE 13 VASCULAR ACCESS DEVICES MARKET FOR ACCESSORIES, BY REGION,
2015–2022 (USD MILLION) 51
TABLE 14 VASCULAR ACCESS DEVICES MARKET, BY APPLICATION,
2015–2022 (USD MILLION) 53
TABLE 15 VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION,
BY REGION, 2015–2022 (USD MILLION) 54
TABLE 16 VASCULAR ACCESS DEVICES MARKET FOR FLUID AND NUTRITION ADMINISTRATION, BY REGION, 2015–2022 (USD MILLION) 55
TABLE 17 VASCULAR ACCESS DEVICES MARKET FOR BLOOD TRANSFUSION,
BY REGION, 2015–2022 (USD MILLION) 55
TABLE 18 VASCULAR ACCESS DEVICES MARKET FOR DIAGNOSTICS AND TESTING,
BY REGION, 2015–2022 (USD MILLION) 56
TABLE 19 VASCULAR ACCESS DEVICES MARKET, BY END USER, 2015–2022 (USD MILLION) 58
TABLE 20 VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY REGION,
2015–2022 (USD MILLION) 59
TABLE 21 VASCULAR ACCESS DEVICES MARKET SIZE FOR CLINICS AND AMBULATORY CARE CENTERS, BY REGION, 2015–2022 (USD MILLION) 60
TABLE 22 VASCULAR ACCESS DEVICES MARKET FOR OTHER END USERS, BY REGION,
2015–2022 (USD MILLION) 60
TABLE 23 VASCULAR ACCESS DEVICES MARKET, BY REGION, 2015-2022 (USD MILLION) 62
TABLE 24 NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET, BY COUNTRY,
2015-2022 (USD MILLION) 64
TABLE 25 NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET, BY TYPE,
2015-2022 (USD MILLION) 64
TABLE 26 NORTH AMERICA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET,
BY TYPE, 2015-2022 (USD MILLION) 64
TABLE 27 NORTH AMERICA: CENTRAL VASCULAR ACCESS DEVICES MARKET, BY TYPE,
2015-2022 (USD MILLION) 65
TABLE 28 NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION,
2015-2022 (USD MILLION) 65
TABLE 29 NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET, BY END USER,
2015-2022 (USD MILLION) 65
TABLE 30 INDICATIVE LIST OF CLINICAL TRIALS CONDUCTED 67
TABLE 31 INDICATIVE LIST OF RECENT EVENTS IN THE U.S. 67
TABLE 32 U.S.: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION) 67
TABLE 33 U.S.: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE,
2015-2022 (USD MILLION) 68
TABLE 34 U.S.: CENTRAL VASCULAR ACCESS DEVICES MARKET, BY TYPE,
2015-2022 (USD MILLION) 68
TABLE 35 U.S.: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION,
2015-2022 (USD MILLION) 68
TABLE 36 U.S.: VASCULAR ACCESS DEVICES MARKET, BY END USER,
2015-2022 (USD MILLION) 69
TABLE 37 CANADA: VASCULAR ACCESS DEVICES MARKET, BY TYPE,
2015-2022 (USD MILLION) 70
TABLE 38 CANADA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE,
2015-2022 (USD MILLION) 70
TABLE 39 CANADA: CENTRAL VASCULAR ACCESS DEVICES MARKET, BY TYPE,
2015-2022 (USD MILLION) 70
TABLE 40 CANADA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION,
2015-2022 (USD MILLION) 71
TABLE 41 CANADA: VASCULAR ACCESS DEVICES MARKET, BY END USER,
2015-2022 (USD MILLION) 71
TABLE 42 GERIATRIC POPULATION IN EUROPEAN COUNTRIES (AS A PERCENTAGE OF THE TOTAL) 73
TABLE 43 EUROPE: VASCULAR ACCESS DEVICES MARKET, BY REGION,
2015-2022 (USD MILLION) 74
TABLE 44 EUROPE: VASCULAR ACCESS DEVICES MARKET, BY TYPE,
2015-2022 (USD MILLION) 74
TABLE 45 EUROPE: PERIPHERAL VASCULAR ACCESS DEVICES MARKET,
BY TYPE, 2015-2022 (USD MILLION) 74
TABLE 46 EUROPE: CENTRAL VASCULAR ACCESS DEVICES MARKET,
BY TYPE, 2015-2022 (USD MILLION) 75
TABLE 47 EUROPE: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION,
2015-2022 (USD MILLION) 75
TABLE 48 EUROPE: VASCULAR ACCESS DEVICES MARKET, BY END USER,
2015-2022 (USD MILLION) 76
TABLE 49 E-3: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION) 78
TABLE 50 E-3: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE,
2015-2022 (USD MILLION) 79
TABLE 51 E-3: CENTRAL VASCULAR ACCESS DEVICES MARKET, BY TYPE,
2015-2022 (USD MILLION) 79
TABLE 52 E-3: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION,
2015-2022 (USD MILLION) 79
TABLE 53 E-3: VASCULAR ACCESS DEVICES MARKET, BY END USER,
2015-2022 (USD MILLION) 80
TABLE 54 ROE: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION) 81
TABLE 55 ROE: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE,
2015-2022 (USD MILLION) 81
TABLE 56 ROE: CENTRAL VASCULAR ACCESS DEVICES MARKET, BY TYPE,
2015-2022 (USD MILLION) 82
TABLE 57 ROE: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION,
2015-2022 (USD MILLION) 82
TABLE 58 ROE: VASCULAR ACCESS DEVICES MARKET, BY END USER,
2015-2022 (USD MILLION) 82
TABLE 59 ASIA-PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY TYPE,
2015-2022 (USD MILLION) 85
TABLE 60 ASIA-PACIFIC: PERIPHERAL VASCULAR ACCESS DEVICES MARKET,
BY TYPE, 2015-2022 (USD MILLION) 85
TABLE 61 ASIA -PACIFIC: CENTRAL VASCULAR ACCESS DEVICES MARKET,
BY TYPE, 2015-2022 (USD MILLION) 85
TABLE 62 ASIA-PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION,
2015-2022 (USD MILLION) 86
TABLE 63 ASIA-PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY END USER,
2015-2022 (USD MILLION) 86
TABLE 64 PERCENTAGE OF OBESE POPULATION IN LATIN AMERICAN COUNTRIES 88
TABLE 65 ROW: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION) 90
TABLE 66 ROW: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE,
2015-2022 (USD MILLION) 90
TABLE 67 ROW: CENTRAL VASCULAR ACCESS DEVICES MARKET, BY TYPE,
2015-2022 (USD MILLION) 90
TABLE 68 ROW: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION,
2015-2022 (USD MILLION) 91
TABLE 69 ROW: VASCULAR ACCESS DEVICES MARKET, BY END USER,
2015-2022 (USD MILLION) 91


LIST OF FIGURES

FIGURE 1 RESEARCH METHODOLOGY: GLOBAL VASCULAR ACCESS DEVICES 17
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 20
FIGURE 3 SAMPLING FRAME: PRIMARY RESEARCH 20
FIGURE 4 KEY DATA FROM PRIMARY SOURCES 21
FIGURE 5 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH 23
FIGURE 6 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 23
FIGURE 7 RESEARCH DESIGN: GLOBAL VASCULAR ACCESS DEVICES 24
FIGURE 8 DATA TRIANGULATION METHODOLOGY 25
FIGURE 9 GLOBAL VASCULAR ACCESS DEVICES MARKET, BY TYPE (2017) 27
FIGURE 10 GLOBAL VASCULAR ACCESS DEVICES MARKET, BY APPLICATION,
2017 VS. 2022 (USD MILLION) 28
FIGURE 11 GLOBAL VASCULAR ACCESS DEVICES MARKET, BY END USER,
2017 VS. 2022 (USD MILLION) 29
FIGURE 12 GEOGRAPHICAL SNAPSHOT OF THE VASCULAR ACCESS DEVICES MARKET 29
FIGURE 13 RISING PREVALENCE OF LIFESTYLE DISEASES IS THE MAJOR FACTOR DRIVING THE GROWTH OF THE VASCULAR ACCESS DEVICES MARKET 31
FIGURE 14 CENTRAL VENOUS ACCESS DEVICES SEGMENT TO ACCOUNT FOR THE LARGEST MARKET SHARE IN 2017 32
FIGURE 15 DRUG ADMINISTRATION SEGMENT WILL CONTINUE TO DOMINATE THE VASCULAR ACCESS DEVICES MARKET DURING THE FORECAST PERIOD 33
FIGURE 16 HOSPITALS SEGMENT TO ACCOUNT FOR THE LARGEST MARKET SHARE IN 2017 33
FIGURE 17 APAC TO REGISTER THE HIGHEST CAGR IN THE FORECAST PERIOD 34
FIGURE 18 GLOBAL VASCULAR ACCESS DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 36
FIGURE 19 CENTRAL VASCULAR ACCESS DEVICES TO COMMAND THE LARGEST SHARE OF THE GLOBAL VASCULAR ACCESS DEVICES MARKET IN 2017 42
FIGURE 20 PERIPHERALLY INSERTED CENTRAL CATHETERS TO COMMAND THE LARGEST SHARE OF THE GLOBAL CENTRAL VASCULAR ACCESS DEVICES MARKET IN 2017 43
FIGURE 21 PERIPHERAL SHORT DEVICES TO COMMAND THE LARGEST SHARE OF THE GLOBAL PERIPHERAL VASCULAR ACCESS DEVICES MARKET IN 2017 48
FIGURE 22 DRUG ADMINISTRATION TO FORM THE LARGEST END-USER SEGMENT IN THE VASCULAR ACCESS DEVICES MARKET IN 2017 53
FIGURE 23 HOSPITALS TO FORM THE LARGEST END-USER SEGMENT IN THE VASCULAR ACCESS DEVICES MARKET IN 2017 58
FIGURE 24 NORTH AMERICA TO DOMINATE THE VASCULAR ACCESS DEVICES MARKET
IN 2017 62
FIGURE 25 NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET SNAPSHOT 63
FIGURE 26 EUROPE: VASCULAR ACCESS DEVICES SNAPSHOT 73
FIGURE 27 CANCER INCIDENCE IN EU-3 77
FIGURE 28 ASIA-PACIFIC: VASCULAR ACCESS DEVICES MARKET SNAPSHOT 84
FIGURE 29 ROW: VASCULAR ACCESS DEVICES MARKET SNAPSHOT 89
FIGURE 30 GLOBAL VASCULAR ACCESS DEVICES MARKET SHARE ANALYSIS, BY KEY PLAYER (2016) 92
FIGURE 31 COMPETITIVE LEADERSHIP MAPPING: VASCULAR ACCESS DEVICE MARKET 94
FIGURE 32 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2016) 97
FIGURE 33 C.R.BARD INC. COMPANY SNAPSHOT (2016) 100
FIGURE 34 TELEFLEX INCORPORATED. COMPANY SNAPSHOT (2016) 103
FIGURE 35 SMITHS MEDICAL INC.: COMPANY SNAPSHOT (2016) 106
FIGURE 36 B BRAUN MELSUNGEN AG COMPANY SNAPSHOT (2016) 109
FIGURE 37 ANGIODYNAMICS COMPANY SNAPSHOT (2016) 113
FIGURE 38 TERUMO CORPORATION: COMPANY SNAPSHOT (2016) 116
FIGURE 39 NIPRO MEDICAL CORPORATION COMPANY SNAPSHOT (2016) 119
FIGURE 40 EDWARDS LIFESCIENCES CORPORATION COMPANY SNAPSHOT (2016) 122


【レポートのキーワード】

血管アクセス器具、医療機器、末梢アクセス、中央アクセス、薬剤投与

【免責事項】
※当レポート上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当レポートに記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当レポート上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチはその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチが翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

[血管アクセスデバイスの世界市場予測(~2022年)]についてメールでお問い合わせはこちら


◆H&Iグローバルリサーチ株式会社のお客様(例)◆